References
[1] Carabello BA, Paulus WJ. Aortic stenosis. Lancet 2009;373:956-966.
[2] Holmes DR, Mack MJ, Kaul S, Agnihotri A, Alexander KP, Bailey SR et al. 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. Journal of the American College of Cardiology 2012;59:1200-1254.
[3] Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002;106:3006-3008.
[4] Mack MJ, Leon MB, Smith CR, Miller DC, Moses JW, Tuzcu EM et al. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 2015;385:2477-2484.
[5] Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK et al. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. The New England Journal of Medicine 2016;374:1609-1620.
[6] Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Fleisher LA et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2017;135:e1159-e1195.
[7] Faroux L, Chen S, Muntané-Carol G, Regueiro A, Philippon F, Sondergaard L et al. Clinical impact of conduction disturbances in transcatheter aortic valve replacement recipients: a systematic review and meta-analysis. European Heart Journal 2020;41:2771-2781.
[8] Popma JJ, Michael Deeb G, Yakubov SJ, Mumtaz M, Gada H, O’Hair D et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. New England Journal of Medicine 2019;380:1706-1715.
[9] Thyregod HG, Steinbrüchel DA, Ihlemann N, Nissen H, Kjeldsen BJ, Petursson P et al. Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis: 1-Year Results From the All-Comers NOTION Randomized Clinical Trial. Journal of the American College of Cardiology 2015;65:2184‐2194.
[10] Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, Gentile F, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2021;143:e72-e227.
[11]Leon MB, Mack MJ, Hahn RT, Thourani VH, Makkar R, Kodali SK et al. Outcomes 2 Years After Transcatheter Aortic Valve Replacement in Patients at Low Surgical Risk. Journal of the American College of Cardiology 2021;77:1149-1161.
[12]Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ 2015;350:g7647.
[13]Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Annals of Internal Medicine 2009;151:W65-94.
[14] Søndergaard L, Steinbrüchel DA, Ihlemann N, Nissen H, Kjeldsen BJ, Petursson P et al. Two-Year Outcomes in Patients With Severe Aortic Valve Stenosis Randomized to Transcatheter Versus Surgical Aortic Valve Replacement: The All-Comers Nordic Aortic Valve Intervention Randomized Clinical Trial. Circulation Cardiovascular interventions 2016;9(6):e003665
[15] Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924-926.
[16]Ades AE, Lu G, Higgins JPT. The interpretation of random-effects meta-analysis in decision models. Medical Decision Making: An International Journal of the Society for Medical Decision Making 2005;25:646-654.
[17]Ioannidis JPA, Patsopoulos NA, Evangelou E. Uncertainty in heterogeneity estimates in meta-analyses. BMJ 2007;335:914-916.
[18]Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-560.
[19]Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-634.
[20]Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088-101.
[21]Kolte D, Vlahakes GJ, Palacios IF, Sakhuja R, Passeri JJ, Inglessis I et al. Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients. Journal of the American College of Cardiology 2019;74:1532-1540.
[22]Makkar RR, Thourani VH, Mack MJ, Kodali SK, Kapadia S, Webb JG et al. Five-Year Outcomes of Transcatheter or Surgical Aortic-Valve Replacement. N Engl J Med 2020;382:799-809.
[23]Van Belle E. TAVR at 5 Years — Rematch or Swan Song for Surgery? New England Journal of Medicine 2020;382:867-868.
[24]Barili F, Freemantle N, Pilozzi Casado A, Rinaldi M, Folliguet T, Musumeci F et al. Mortality in trials on transcatheter aortic valve implantation versus surgical aortic valve replacement: a pooled meta-analysis of Kaplan–Meier-derived individual patient data. European Journal of Cardio-Thoracic Surgery 2020;58:221-229.
[25]Deharo P, Bisson A, Herbert J, Lacour T, Saint Etienne C, Grammatico-Guillon L, et al. Impact of Sapien 3 Balloon-Expandable Versus Evolut R Self-Expandable Transcatheter Aortic Valve Implantation in Patients With Aortic Stenosis: Data From a Nationwide Analysis. Circulation 2020;141:260-268.
[26]Schymik G, Schröfel H, Heimeshoff M, Luik A, Thoenes M, Mandinov L.. How to adapt the implantation technique for the new SAPIEN 3 transcatheter heart valve design. Journal of interventional cardiology 2015;28:82-89.
[27]Jørgensen TH, De Backer O, Gerds TA, Bieliauskas G, Svendsen JH, Søndergaard L.. Mortality and Heart Failure Hospitalization in Patients With Conduction Abnormalities After Transcatheter Aortic Valve Replacement. JACC Cardiovascular interventions 2019;12:52-61.
[28]Danny D, John W, Stephen B, Sabine B, David H-S, Antonio C et al. Transcatheter Aortic Valve Replacement for Degenerative Bioprosthetic Surgical Valves. Circulation 2012;126:2335-2344.
[29]Bidar E, Folliguet T, Kluin J, Muneretto C, Parolari A, Barili F et al. Postimplant biological aortic prosthesis degeneration: challenges in transcatheter valve implants. European Journal of Cardio-Thoracic Surgery: Official Journal of the European Association for Cardio-Thoracic Surgery 2019;55:191-200.
[30]Thyregod HGH, Ihlemann N, Jørgensen TH, Nissen H, Kjeldsen BJ, Petursson P et al. Five-Year Clinical and Echocardiographic Outcomes from the Nordic Aortic Valve Intervention (NOTION) Randomized Clinical Trial in Lower Surgical Risk Patients. Circulation 2019;139:2714-2723.